Stuart Chaussee & Associates’s Chemed CHE Stock Holding History

Stuart Chaussee & Associates’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10	Closed	-$5K	–	168
2021 Q1	$5K	Buy	+10	New	+$4.9K	﹤0.01%	166

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Stuart Chaussee & Associates's CHE Position: Q2 2021 in Review

Stuart Chaussee & Associates sold out of Chemed (CHE) in Q2 2021, closing a stake of 10 shares — an estimated $5K sold.

Stuart Chaussee & Associates first reported a position in CHE in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2021.

Stuart Chaussee & Associates reported no remaining Chemed position as of Q2 2021 after selling out during the quarter.
Stuart Chaussee & Associates sold 10 Chemed shares in Q2 2021, an estimated $5K.
Stuart Chaussee & Associates first reported a position in Chemed in Q1 2021 and held it in 1 quarter.
Stuart Chaussee & Associates's Chemed position peaked at $5K in Q1 2021.
425 funds tracked by Wall St. Rank held Chemed as of Q2 2021.

Based on Stuart Chaussee & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.